相关实验视频

Updated: Mar 15, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

失糖症和心脏代谢风险:病理生理学理由和营养药在综合预防中的新兴作用

Arrigo Francesco Giuseppe Cicero^1,2, Giovanni Scapagnini³, Davide Grassi⁴

¹Cardiovascular Medicine Unit, Heart, Chest and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

|March 14, 2026

概括

营养药物为治疗失糖症提供了支持的方法,失糖症是心脏代谢疾病的前体. 这些天然化合物有助于改善血糖控制和代谢健康,弥合生活方式干预和药物治疗.

科学领域:

心脏代谢健康状况
营养科学营养科学
预防医学预防医学

背景情况:

失糖症的特点是胰岛素抵抗和炎症,是心脏代谢疾病的早期阶段,患病率很高.
它的无症状性往往导致诊断和干预延迟,突出显示了需要主动策略的需要.
承认失糖症是一种连续性,强调综合预防方法.

研究的目的:

探索营养药作为治疗失糖症的辅助工具的作用.
研究营养药是如何向失糖症的关键病理生理机制的.
评估营养药在改善血糖控制和延迟2型糖尿病进展方面的潜力.

主要方法:

对营养保健品的临床证据的审查,包括微量营养素,多和植物提取物.
对特定植物复合物的作用机制的分析 (例如,Mangifera indica,Momordica charantia,Malus domestica).
评估营养药与生活方式和饮食干预措施的整合.

主要成果:

临床证据支持使用精选的营养药物来改善禁食和食后血糖控制.
植物复合体表现出多重目标作用,包括调节碳水化合物吸收和增强葡萄糖吸收.
营养药,当与生活方式的改变相结合时,可能会降低血糖的变化,并延迟进展到2型糖尿病.

结论:

营养药物是治疗失糖症的宝贵补充剂,特别是在尚未需要药物治疗的风险人群中.
他们准关键机制,如胰岛素敏感性,氧化应激和炎症.
营养药物作为生活方式改变和药物治疗在个性化失糖症管理之间的合理联系.

关键词:

心脏代谢的发生.糖尿病糖尿病患者糖尿病患者饮食饮食饮食饮食失糖症失糖症失糖症葡萄糖葡萄糖葡萄糖是一种在这种情况下,胰岛素胰岛素胰岛素.微量营养素微量营养素营养保健品营养保健品植物复合体是一种植物复合体.

更多相关视频

A Model of Chronic Nutrient Infusion in the Rat

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Overview of Carbohydrate Metabolism

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...